Table 1 Comparison of general clinical data before and after PSM in RI group and no-RI group
Before PSM | After PSM | ||||||
|---|---|---|---|---|---|---|---|
RI group (N = 100) | No-RI group (N = 100) | P | RI group (N = 52) | No-RI group (N = 52) | P | ||
Age (years) | 64.00(17) | 57.00(16) | 0.022& | 61.94 ± 9.89 | 60.58 ± 11.12 | 0.510* | |
Gender (n%) | |||||||
male | 57(57.0%) | 44(44.0%) | 0.066# | 30(57.7%) | 21(40.4) | 0.078# | |
female | 43(43.0%) | 56(56.0%) | 22(42.3%) | 31(59.6%) | |||
hypertension (n%) | |||||||
yes | 59(59.0%) | 49(49.0%) | 0.156# | 31(59.6%) | 26(50.0%) | 0.325# | |
no | 41(41.0%) | 51(51.0%) | 21(40.4%) | 26(50.0%) | |||
diabetes (n%) | |||||||
yes | 41(41.0%) | 21(21.0%) | 0.002# | 15(28.8%) | 13(25.0%) | 0.658# | |
no | 59(59.0%) | 79(79.0%) | 37(71.2%) | 39(75.0%) | |||
hyperlipidemia (n%) | |||||||
yes | 17(17.0%) | 9(9.0%) | 0.093# | 7(13.5%) | 6(11.5%) | 0.767# | |
no | 83(83.0%) | 91(91.0%) | 45(86.5%) | 46(88.5%) | |||
smoke(n%) | |||||||
yes | 17(17.0%) | 13(13.0%) | 0.428# | 7(13.5%) | 7(13.5%) | 1.000# | |
no | 83(83.0%) | 87(87.0%) | 45(86.5%) | 45(86.5%) | |||
∠LAD-LCX(°) | 90.50(33) | 58.50(31) | < 0.001& | 74.81 ± 20.64 | 75.92 ± 20.04 | 0.780* |